Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin.

Vianna JS, Machado D, Ramis IB, Silva FP, Bierhals DV, Abril MA, von Groll A, Ramos DF, Lourenço MCS, Viveiros M, da Silva PEA.

Antibiotics (Basel). 2019 Sep 18;8(3). pii: E153. doi: 10.3390/antibiotics8030153.

2.

In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus.

Ramis IB, Vianna JS, Silva Junior L, von Groll A, Ramos DF, Lobo MM, Zanatta N, Viveiros M, Silva PEAD.

Tuberculosis (Edinb). 2019 Jul 23;118:101853. doi: 10.1016/j.tube.2019.07.004. [Epub ahead of print]

PMID:
31430699
3.

Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis.

Reis WJ, Bozzi ÍAO, Ribeiro MF, Halicki PCB, Ferreira LA, Almeida da Silva PE, Ramos DF, de Simone CA, da Silva Júnior EN.

Bioorg Med Chem. 2019 Sep 15;27(18):4143-4150. doi: 10.1016/j.bmc.2019.07.045. Epub 2019 Jul 27.

PMID:
31378595
4.

Biological activity of aqueous extracts of Southern Brazilian mushrooms.

Volcão LM, Halicki PB, Bilibio D, Ramos DF, Bernardi E, Da Silva Júnior FMR.

Int J Environ Health Res. 2019 Jul 1:1-12. doi: 10.1080/09603123.2019.1634798. [Epub ahead of print]

PMID:
31257910
5.

Traditional detoxification of Jatropha curcas L. seeds.

Albino RC, Antoniassi R, de Faria-Machado AF, Ferraris FK, Amendoeira FC, Ramos DF, Silva PEA, Leitão SG, Oliveira DR.

J Ethnopharmacol. 2019 Sep 15;241:111970. doi: 10.1016/j.jep.2019.111970. Epub 2019 May 22.

PMID:
31128150
6.

Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus.

Vianna JS, Ramis IB, Bierhals D, von Groll A, Ramos DF, Zanatta N, Lourenço MC, Viveiros M, Almeida da Silva PE.

J Glob Antimicrob Resist. 2019 Jun;17:296-299. doi: 10.1016/j.jgar.2018.12.020. Epub 2019 Jan 7.

PMID:
30630106
7.

Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin.

Halicki PCB, Hädrich G, Boschero R, Ferreira LA, von Groll A, da Silva PEA, Dora CL, Ramos DF.

Assay Drug Dev Technol. 2018 Oct 16. doi: 10.1089/adt.2018.874. [Epub ahead of print]

PMID:
30325673
8.

Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.

Corrêa Barros LP, Del Rio KP, Carvalho TDSC, Pinto MDCFR, de Moura KCG, Halicki PCB, Ramos DF, da Silva PEA.

Tuberculosis (Edinb). 2018 Jul;111:198-201. doi: 10.1016/j.tube.2018.06.015. Epub 2018 Jul 3.

PMID:
30029908
9.

The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori.

Vianna JS, Ramis IB, Ramos DF, Gastal OL, Silva RAD, Gonçalves CV, Silva PEAD.

Rev Inst Med Trop Sao Paulo. 2018;60:e25. doi: 10.1590/s1678-9946201860025. Epub 2018 Jun 28.

10.

Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus.

Ramis IB, Vianna JS, Reis AJ, von Groll A, Ramos DF, Viveiros M, da Silva PEA.

Planta Med. 2018 Nov;84(17):1265-1270. doi: 10.1055/a-0639-5412. Epub 2018 Jun 18.

PMID:
29913527
11.

Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.

Halicki PCB, Ferreira LA, De Moura KCG, Carneiro PF, Del Rio KP, Carvalho TDSC, Pinto MDCFR, da Silva PEA, Ramos DF.

Front Microbiol. 2018 Apr 9;9:673. doi: 10.3389/fmicb.2018.00673. eCollection 2018.

12.

High frequency of aac(6')-Ib-cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections.

Volcão LM, Lacava JP, Gewehr MF, Leal VL, Ramis IB, Ramos DF, Gonçalves CV, Possuelo LG, Minarini LAR, da Silva PEA, von Groll A.

J Glob Antimicrob Resist. 2018 Jun;13:180-183. doi: 10.1016/j.jgar.2017.12.013. Epub 2018 Jan 4.

PMID:
29307860
13.

Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.

Ramis IB, Figueiredo R, Ramos DF, Halicki PCB, von Groll A, Viveiros M, do Ceu Costa M, da Silva PEA.

Med Chem. 2018;14(4):394-399. doi: 10.2174/1573406414666171204102633.

PMID:
29205119
14.

Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis.

Machado D, Coelho TS, Perdigão J, Pereira C, Couto I, Portugal I, Maschmann RA, Ramos DF, von Groll A, Rossetti MLR, Silva PA, Viveiros M.

Front Microbiol. 2017 Apr 27;8:711. doi: 10.3389/fmicb.2017.00711. eCollection 2017.

15.

In vitro and in silico analysis of the efficiency of tetrahydropyridines as drug efflux inhibitors in Escherichia coli.

Silva L Jr, Carrion LL, von Groll A, Costa SS, Junqueira E, Ramos DF, Cantos J, Seus VR, Couto I, Fernandes LD, Bonacorso HG, Martins MA, Zanatta N, Viveiros M, Machado KS, Almeida da Silva PE.

Int J Antimicrob Agents. 2017 Mar;49(3):308-314. doi: 10.1016/j.ijantimicag.2016.11.024. Epub 2017 Jan 30.

16.

DRUG RESISTANCE IN HELICOBACTER PYLORI.

Vianna JS, Ramis IB, Ramos DF, VON Groll A, Silva PE.

Arq Gastroenterol. 2016 Oct-Dec;53(4):215-223. doi: 10.1590/S0004-28032016000400002. Review.

17.

The BACTEC MGIT(tm) 320 system as a laboratory tool to diagnose tuberculosis in a Brazilian hospital with a high prevalence of HIV infection.

Brum CB, Ramos DF, Abilleira Fde S, Silva AB, von Groll A, Silva PE.

Rev Soc Bras Med Trop. 2016 Feb;49(1):112-4. doi: 10.1590/0037-8682-0125-2015.

18.

Diagnosis of bovine tuberculosis: review of main techniques.

Ramos DF, Silva PE, Dellagostin OA.

Braz J Biol. 2015 Nov;75(4):830-7. doi: 10.1590/1519-6984.23613. Epub 2015 Nov 10. Review.

19.

Antimycobacterial and cytotoxicity activity of microcystins.

Ramos DF, Matthiensen A, Colvara W, de Votto AP, Trindade GS, da Silva PE, Yunes JS.

J Venom Anim Toxins Incl Trop Dis. 2015 Mar 20;21:9. doi: 10.1186/s40409-015-0009-8. eCollection 2015.

20.

Molecular typing of Mycobacterium bovis isolated in the south of Brazil.

Ramos DF, Silva AB, Fagundes MQ, von Groll A, da Silva PE, Dellagostin OA.

Braz J Microbiol. 2014 Aug 29;45(2):657-60. eCollection 2014.

21.

Molecular typing of Mycobacterium bovis isolates: a review.

Ramos DF, Tavares L, da Silva PE, Dellagostin OA.

Braz J Microbiol. 2014 Aug 29;45(2):365-72. eCollection 2014. Review.

22.

Activity of 4,5-dihydro-1H-pyrazoles against Mycobacterium tuberculosis and nontuberculous mycobacteria.

Ramos DF, Fiss G, Frizzo CP, Martins MA, Bonacorso HG, Zanatta N, Almeida da Silva PE.

Int J Antimicrob Agents. 2014 May;43(5):481-3. doi: 10.1016/j.ijantimicag.2014.02.004. Epub 2014 Mar 16. No abstract available.

PMID:
24713182
23.

Triterpenes and the antimycobacterial activity of Duroia macrophylla Huber (Rubiaceae).

Martins D, Carrion LL, Ramos DF, Salomé KS, da Silva PE, Barison A, Nunez CV.

Biomed Res Int. 2013;2013:605831. doi: 10.1155/2013/605831. Epub 2013 Feb 12.

24.

Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes.

Spies FS, von Groll A, Ribeiro AW, Ramos DF, Ribeiro MO, Dalla Costa ER, Martin A, Palomino JC, Rossetti ML, Zaha A, da Silva PE.

Tuberculosis (Edinb). 2013 Mar;93(2):150-4. doi: 10.1016/j.tube.2012.11.004. Epub 2012 Dec 29.

PMID:
23276692
25.

Rational design of diagnostic and vaccination strategies for tuberculosis.

Borsuk S, Seixas FK, Ramos DF, Mendum T, McFadden J, Dellagostin O.

Braz J Infect Dis. 2012 Jan-Feb;16(1):68-73.

26.

Multiple strains of Mycobacterium bovis revealed by molecular typing in a herd of cattle.

Figueiredo EE, Ramos DF, Medeiros L, Silvestre FG, Lilenbaum W, Silva JT, Paschoalin VM, Dellagostin OA.

Vet J. 2012 Jul;193(1):296-8. doi: 10.1016/j.tvjl.2011.11.006. Epub 2011 Dec 16.

PMID:
22178356
27.

Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolates.

Figueiredo R, Ramos DF, Moiteiro C, Medeiros MA, Marcelo Curto MJ, Cardoso de Menezes J, Pando RH, Silva PE, Costa Mdo C.

Eur J Med Chem. 2012 Jan;47(1):186-93. doi: 10.1016/j.ejmech.2011.10.041. Epub 2011 Nov 4.

PMID:
22100303
28.

Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene.

Spies FS, Ribeiro AW, Ramos DF, Ribeiro MO, Martin A, Palomino JC, Rossetti ML, da Silva PE, Zaha A.

J Clin Microbiol. 2011 Jul;49(7):2625-30. doi: 10.1128/JCM.00168-11. Epub 2011 May 18.

29.

Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations.

Coelho MB, Costa ER, Vasconcellos SE, Linck N, Ramos RM, Amorim HL, Suffys PN, Santos AR, Silva PE, Ramos DF, Silva MS, Rossetti ML.

Mutat Res. 2011 Jul 1;712(1-2):33-9. doi: 10.1016/j.mrfmmm.2011.03.017. Epub 2011 Apr 14.

PMID:
21514309
30.

Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

Ramos DF, Almeida da Silva PE.

Pharm Biol. 2010 Mar;48(3):260-3. doi: 10.3109/13880200903085490.

PMID:
20645810
31.

Chemical composition and antimycobacterial activity of the essential oil from Anemia tomentosa var. anthriscifolia.

Pinto SC, Leitão GG, de Oliveira DR, Bizzo HR, Ramos DF, Coelho TS, Silva PE, Lourenço MC, Leitão SG.

Nat Prod Commun. 2009 Dec;4(12):1675-8.

PMID:
20120105
32.

New anti-tuberculosis drugs: strategies, sources and new molecules.

Palomino JC, Ramos DF, da Silva PA.

Curr Med Chem. 2009;16(15):1898-904. Review.

PMID:
19442153
33.

Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.

Almeida da Silva PE, Ramos DF, Bonacorso HG, de la Iglesia AI, Oliveira MR, Coelho T, Navarini J, Morbidoni HR, Zanatta N, Martins MA.

Int J Antimicrob Agents. 2008 Aug;32(2):139-44. doi: 10.1016/j.ijantimicag.2008.03.019. Epub 2008 Jun 20.

PMID:
18571384
34.

The laboratory as a tool to qualify tuberculosis diagnosis.

Honscha G, Von Groll A, Valença M, Ramos DF, Sanchotene K, Scaini CJ, Ribeiro MO, da Silva PE.

Int J Tuberc Lung Dis. 2008 Feb;12(2):218-20.

PMID:
18230257
35.

Comparative cytotoxic and anti-tuberculosis activity of Aplysina caissara marine sponge crude extracts.

Azevedo LG, Muccillo-Baisch AL, Filgueira Dde M, Boyle RT, Ramos DF, Soares AD, Lerner C, Silva PA, Trindade GS.

Comp Biochem Physiol C Toxicol Pharmacol. 2008 Jan;147(1):36-42. Epub 2007 Aug 1.

PMID:
17826358
36.

A study of the forces produced by various preformed uprighting springs.

Ramos DF, Weimer AD, Hanna M.

Am J Orthod. 1979 Dec;76(6):637-45. No abstract available.

PMID:
293133
37.

Public Health as an Important Part of Pan American Defense.

Ramos DF.

Am J Public Health Nations Health. 1942 Jun;32(6):627-30. No abstract available.

Supplemental Content

Loading ...
Support Center